This website uses cookies to store information on your computer. Some of these cookies are used for visitor analysis, others are essential to making our site function properly and improve the user experience. By using this site, you consent to the placement of these cookies. Click Accept to consent and dismiss this message or Deny to leave this website. Read our Privacy Statement for more.
Print Page   |   Contact Us   |   Sign In   |   Register
Community Search
CASSS Associate Directors
Share |

Our Leadership

Board of Directors

Associate Directors

Distinguished Fellows

Staff

 

 

 

 

Digital Strategy Report

 

    

Associate Directors (ADs) are “statutory members” of CASSS.  Membership in this committee is open to all who have participated as a volunteer on any of the CASSS meeting committees and who actively parcticipate in AD activities. In most professional societies you pay dues to join the organization.  In this way, CASSS is unique.  Our “dues” are participation instead of a monetary payment.  CASSS' ADs are a select group of members, made up of those who care enough about the organization to not just send in an annual check but actually contribute their time and expertise.  This is what gives us our strength. The ADs are also the members of CASSS charged with electing the Board and advising them on issues of importance to the membership-at-large.

Siddharth Advant, Celgene Corporation, USA

Wasfi Al-Azzam, TechnoPharmaSphere LLC, USA

Justin E. Aldridge, Biogen, USA

Kris Antonsen, BioMarin Pharmaceutical Inc., USA

Thomas W. Arroll, Seattle Genetics, Inc., USA

Yves Aubin, Health Canada, Canada

Sandra Auguste-Bower, H. Lundbeck A/S, Denmark

Evangelos Bakopanos, Health Canada, Canada

Jared Bee, MacroGenics, Inc., USA

Edna Betgovargez, Beckman Coulter, Inc., USA

Timothy Blanc, Eli Lilly and Company, USA

Markus Blümel, Novartis Pharma AG, Switzerland

Michael Boyne, COUR Pharmaceuticals Development Company, Inc., USA

Michael Brenowitz, Albert Einstein College of Medicine, USA

Greg Cantin, Five Prime Therapeutics Inc, USA

Holly Cargill, Pfizer, Inc., USA

David Carr, Bioanalytical Technologies, USA

James Carroll, Pfizer, Inc., USA

Jennifer Chadwick, BioAnalytix, Inc., USA

Andrew Chang, Novo Nordisk Inc., USA

Michael B. Chang, PTC Therapeutics, USA

Emmanuelle Charton, EDQM, Council of Europe, France

Guodong Chen, Bristol-Myers Squibb Company, USA

Barry Cherney, Amgen Inc., USA

Judy Chou, Bayer, USA

Natalie Ciaccio, BioMarin Pharmaceutical Inc., USA

David Cirelli, Pfizer, Inc., USA

Steven A. Cohen, SAC Analytical Consultants, USA

Mary Cromwell, Genentech, a Member of the Roche Group, USA

Robert Cunico, Pacific Biolabs, USA

Xiao-Ping Dai, WuXi Advanced Therapies, USA

Eef Dirksen, Synthon Biopharmaceuticals B.V., Netherlands

Bharat Dixit, ClearB Therapeutics, USA

John R. Dobbins, Eli Lilly and Company, USA

Vladislav Dolnik, USA

Narasaiah Dontha, Celgene Corporation, USA

Roman T. Drews, Daiichi Sankyo, Inc., USA

Anders Dybdal Nielsen, LEO Pharma A/S, Denmark

Julia Edwards, Genentech, a Member of the Roche Group, USA

William Egan, GSK Vaccines, USA

Christof Finkler, F. Hoffmann - La Roche Ltd., Switzerland

Frantisek Foret, Institute of Analytical Chemistry ASCR, v.v.i., Czech Republic

Kathleen Francissen, Genentech, a Member of the Roche Group, USA

Michelle R. Frazier, USA

John Frenz, Northeastern University, USA

Marta Germano, Janssen Vaccines and Prevention, Netherlands

Joseph Glajch, JLG AP Consulting LLC, USA

Ralf Gleixner, Ares Trading SA, An affiliate of Merck Serono, Switzerland

Andras Guttman, SCIEX, USA

Fadi Hakki, Viela Bio, USA

Jason Hampson, Amgen Inc., USA

Mei Han, Amgen Inc., USA

Stephen E. Hartman, AbbVie Biotherapeutics, USA

Julie Heflin, Abbvie Inc., USA

John P. Hennessey Jr., Independent Consultant, USA

John Hobbs, Beckman Coulter, Inc., USA

Damian Houde, Codiak Biosciences, USA

Ping Hu, Janssen Pharmaceutical R&D, LLC, USA

Chi-Ting Huang, Surface Oncology, USA

Brendan P. Hughes, Bristol-Myers Squibb Company, USA

Ronald Imhoff, Janssen Vaccines and Prevention, Netherlands

Guifeng Jiang, Boehringer Ingelheim Pharmaceuticals, Inc., USA

Xu-Rong Jiang, AstraZeneca BioVentures, USA

Carmilia Jimenez Ramirez, Ajinomoto Bio-Pharma Services, USA

Peter R. Johnson, Retired, USA

Franka Kalman, HES-SO Valais, Switzerland

Vinaya Kapoor, Tricida, USA

Jon S. Kauffman, Eurofins Advantar, USA

Sarah Kennett, Genentech, a Member of the Roche Group, USA

Maura Kibbey, USP, USA

Steffen Kiessig, F. Hoffmann - La Roche Ltd., Switzerland

John Kim, Teva Pharmaceuticals, USA

Kevin R. King, Pfizer, Inc., USA

Alistair Kippen, IPSEN Biopharm Ltd., United Kingdom

Yasuhiro Kishioka, Pharmaceuticals and Medical Devices Agency (PMDA), Japan

Junichi Koga, Daiichi Sankyo Co., Ltd., Japan

Carol Krantz, Seattle Genetics, Inc., USA

Robert Kuhn, Amgen Inc., USA

Joseph Kutza, AstraZeneca, USA

Nathan Lacher, Pfizer, Inc., USA

David Lee, bluebird bio, Inc., USA

Inui Lee, Kobe University, Japan

Kathy Lee, Eli Lilly and Company, USA

Patricia Lewis, Alpine Immune Sciences, USA

Vivian Lindo, MedImmune Limited, United Kingdom

Aston Liu, GlaxoSmithKline, USA

Anthony S. Lubiniecki, University of Maryland, USA

Anders Lund, Synlogic, USA

Jiann-Kae Luo, Regeneron Pharmaceuticals, Inc., USA

Michelle L. Lytle, Eli Lilly and Company, USA

Yelena Lyubarskaya, Sanofi, USA

Mirek Macka, University of Tasmania, Australia

Helena Madden, Biogen, USA

Khalid Mahmood, Eli Lilly and Company, USA

John P. Marino, National Institute of Standards and Technology (NIST), USA

Ingrid Markovic, Genentech, a Member of the Roche Group, USA

Philip Marriott, Australia

William Matousek, Regeneron Pharmaceuticals, Inc., USA

Noriyuki Matsumoto, Retired, Japan

Robert Mattaliano, USA

Rob McCombie, Sangamo Therapeutics, Inc., USA

Bruce Meiklejohn, Meiklejohn Consulting, USA

David Michels, Genentech, a Member of the Roche Group, USA

Kenneth Miller, AstraZeneca, USA

Thomas A. Millward, Novartis Pharma AG, Switzerland

Anthony Mire-Sluis, AstraZeneca, USA

Edwin Moore, University of Illinois, USA

Jamie Moore, Genentech, a Member of the Roche Group, USA

Genesio Murano, BioScope Associates, USA

Linda O. Narhi, Amgen Inc., USA

Wassim Nashabeh, F. Hoffmann - La Roche Ltd., USA

Jens Bjørn Nielsen, Novo Nordisk A/S, Denmark

Shawn Novick, Retired, USA

Brian K. Nunnally, Seqirus, a CSL Company, USA

Fionnuala O'Driscoll, Eli Lilly Kinsale Limited, Ireland

Julia O'Neill, Direxa Consulting, USA

Bhavin Parekh, Eli Lilly and Company, USA

Jun Park, ViroMed Co., Ltd, South Korea

Sungae S. Park, Samsung Bioepis Co., Ltd., South Korea

David Passmore, RubrYc Therapeutics, USA

Mary Beth Pelletier, Biogen, USA

Stefanie Pluschkell, Pfizer, Inc., USA

Christopher A. Pohl, USA

Francis Poulin, Sanofi, USA

Lesley Redfern, AbbVie Inc., USA

Gang Ren, Lawrence Berkeley National Laboratory, USA

Daisy Richardson, Merck & Co., Inc., USA

Anthony Ridgway, Health Canada, Canada

Noel J. Rieder, Amgen Inc., USA

Nadine M. Ritter, Global Biotech Experts, LLC, USA

Sushmita (Mimi) Roy, BioMarin Pharmaceutical Inc., USA

Margaret Ruesch, Pfizer, Inc., USA

Reb Russell, Jazz Pharmaceuticals, Inc., USA

Richard Rustandi, Merck & Co., Inc., USA

Michael Sadick, Catalent Pharma Solutions, USA

Oscar Salas-Solano, Sana Biotechnology, a Member of the Roche Group, USA

Catharina Sänger van de Griend, Kantisto BV, Netherlands

Mark Schenerman, CMC Biotech-MAS Consulting, USA

John E. Schiel, National Institute of Standards and Technology (NIST), USA

Martin Schiestl, Sandoz GmbH, Austria

Timothy Schofield, CMC Sciences, LLC, USA

Thomas Schreitmueller, F. Hoffmann - La Roche Ltd., Switzerland

Sally S. Seaver, Retired, USA

Joanne Severs, Bayer Pharma AG, USA

Karin Sewerin, BioPharmaLinx AB, Sweden

Zahra Shahrokh, ZDev Consulting and STC Biologics, USA

Joseph Siemiatkoski, J. Siemiatkoski Consulting, USA

Satish K. Singh, Lonza AG, USA

Robert Sitrin, PATH, USA

Lance Smallshaw, UCB Biopharma sprl.Belgium

Zoran Sosic, Biogen, USA

Kannan Srinivasan, USA

Arne Staby, Novo Nordisk A/S, Denmark

Jeff Staecker, BioPhia Consulting, Inc., USA

Robert L. Stevenson, American Laboratory/Labcompare, USA

Annie Sturgess, Bristol-Myers Squibb Company, USA

Shelley D. Suggett, Halozyme Therapeutics, USA

Frantisek Svec, Lawrence Berkeley National Laboratory, USA

Patrick Swann, Amgen Inc., USA

Jonathan Sweedler, University of Illinois at Urbana-Champaign, USA

Garry Takle, Merck & Co., Inc., USA

Harold V. Taylor, Merz Pharma GmbH & Co KGaA, Germany

Max L. Tejada, AstraZeneca, USA

Hansjoerg Toll, Novartis, Austria

Kazuhisa Uchida, Kobe University, Japan

Paul Varley, Kymab, United Kingdom

Kimberly M. Vazquez, Immunomedics, USA

Michael W. Washabaugh, Adello Biologics, LLC, USA

Hermann Wätzig, University of Braunschweig, Germany

Ziping Wei, BridgeBio LLC, USA

Andrew Weiskopf, Biogen, USA

William Weiss, Eli Lilly and Company, USA

Jolanda Westerlaken, UCB Pharma SA, Canada

Lance Wong, Strand Bio, USA

Jason S. Wood, 908 Devices, Inc., USA

Philip Wyatt, Wyatt Technology CorporationUSA

Jette Wypych, Amgen Inc., USA

Yuan Xu, Legend Biotech, USA

Toyohiko Yamamoto, Asahi Kasei Pharma CorporationJapan

Min Young, Ultragenyx Pharmaceutical Inc., USA

Christopher Yu, Genentech, a Member of the Roche Group, USA

Heidi Zhang, Juno Therapeutics, A Celgene Company, USA

Eike Zimmermann, Boehringer Ingelheim Pharmaceuticals, Inc., USA


 

    

 

more Calendar

9/17/2019 » 9/20/2019
Mass Spec 2019

9/29/2019 » 10/2/2019
CE Pharm 2019

Membership Software Powered by YourMembership  ::  Legal